Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 51: 1026-1029, 2005; 10.1373/clinchem.2005.048454
This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Holdenrieder, S.
Right arrow Articles by Stieber, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Holdenrieder, S.
Right arrow Articles by Stieber, P.
Related Collections
Right arrow Molecular Diagnostics and Genetics
(Clinical Chemistry. 2005;51:1026-1029.)
© 2005 American Association for Clinical Chemistry, Inc.


Technical Briefs

Stability of Nucleosomal DNA Fragments in Serum

Stefan Holdenriedera, Susanne Mueller and Petra Stieber

Institute of Clinical Chemistry, University of Munich, Munich, Germany;

aaddress correspondence to this author at: University Hospital of Munich-Grosshadern, Institute of Clinical Chemistry, Marchioninistrasse 15, D-81377 Munich, Germany; fax 49-89-7095-6298, e-mail Stefan.Holdenrieder{at}.med.uni-muenchen.de

Circulating DNA is increased in various benign and malignant pathologic conditions, including cancers, sepsis, and graft-vs-host and autoimmune diseases as well as after trauma or ischemia (1)(2)(3)(4)(5)(6)(7)(8). Changes in circulating DNA correlate with the response to antitumor therapy and with tumor recurrence (9)(10)(11). Furthermore, DNA concentration reportedly has predictive and prognostic relevance in cancer (11)(12). Despite the nonspecific nature of circulating DNA, it might have considerable potential for monitoring cancer and management of therapy (9)(10)(11)(12).

In serum and plasma, DNA is thought to exist predominantly as mono- and oligonucleosomes (13)(14), which are formed by a core particle of a double set of the histones H2A, H2B, H3, and H4 wrapped by 146 bp of DNA on the outside (15). By this composition they seem to be protected against rapid digestion by endonucleases (16). Circulating nucleosomes can be quantified by real-time PCR of the DNA but also by immunologic assays, which are particularly well suited for serial measurements (17).

Achieving reliable results in these immunochemical assays requires adherence to a strict preanalytical protocol that includes careful venipuncture, centrifugation of the sample within 1–2 h after venipuncture, addition of EDTA for stabilization of nucleosomes, and storage at –70 °C if measurement is to be delayed. This procedure is based on our earlier studies on preanalytical factors that could influence the nucleosome concentrations between venipuncture and centrifugation, between centrifugation and EDTA addition, between EDTA addition and freezing, during long-term storage, and between thawing and test performance (17). Our results indicated that a delay between venipuncture and centrifugation can lead to a time-dependent increase in nucleosome concentrations, which was most pronounced at 37 °C, whereas a delay in EDTA addition after centrifugation was associated with a time-dependent decrease in results (17).

In many instances, blood samples are transported to the laboratory by mail; we therefore investigated various additional preanalytical conditions that might influence the stability of nucleosomes in serum during shipping: Sera from 5 volunteers were exposed to prolonged time of transportation, different temperatures, shaking and rolling, several freeze–thaw cycles, and measurements with various delays after thawing. In all experiments, the samples were centrifuged, within 30 min after venipuncture, at 3000g for 15 min and stabilized with 10 mmol/L EDTA (pH 8) immediately after centrifugation. Subsequently, they were aliquoted, and methodical experiments were performed. They were then stored at –70 °C and analyzed in batches containing all samples from a single patient.

The nucleosome ELISA (Cell Death Detection ELISAplus; Roche Diagnostics) is based on a quantitative sandwich enzyme immunoassay principle: Monoclonal mouse antibodies directed against DNA (single- and double-stranded DNA) and histones (H1, H2A, H2B, H3, and H4) detect specifically mono- and oligonucleosomes. The anti-histone antibody is bound to the microtiter plate, whereas the anti-DNA antibody labeled with peroxidase reacts with 2,2'-azino-di(3-ethylbenzthiazoline-sulfonate). The amount of captured nucleosomes is proportional to the resulting color development and enables spectrophotometric quantification in arbitrary units (17).

In the first experiment, we varied the time between stabilization of the sera with EDTA and storage at –70 °C (1, 2, 3, 4, 6, and 24 h and 2, 3, and 7 days), and samples were stored at various temperatures during that time (4, 25, and 37 °C) to simulate potential stressful transportation conditions. Prolonged "transportation time" clearly did not influence the values in those stabilized sera that were stored at 4 and 25 °C. The median SD for all time points was <10%. At 37 °C, however, the values decreased continually, and after 24 h, only approximately one-half of the initial concentration remained (median SD, 50.2%; Fig. 1 , A–F).



View larger version (36K):
[in this window]
[in a new window]
 
Figure 1. Results of the experiments on preanalytical conditions, shown in absolute nucleosome concentrations [measured in arbitrary units (AU)] and deviations (%) from the concentrations measured under standard conditions.

(A–F), serum samples were stabilized with 10 mmol/L EDTA, aliquoted, and incubated for 1, 2, 3, 4, 6, and 24 h and 2, 3, and 7 days, respectively, at 4, 25, and 37 °C, respectively, before storage at –70 °C and nucleosome measurement. Samples showed only minor changes when incubated at 4 and 25 °C, whereas a considerable decrease was observed after incubation at 37 °C. (G and H), stabilized sera were vortex-mixed for 5, 10, and 30 s or, alternatively, rolled in an overhead roller for 15 and 30 min. They were then stored at 25 or at 37 °C for 4 h before being frozen at –70 °C. Neither shaking nor rolling influenced the measured nucleosome concentrations, but after incubation at 37 °C, the measured concentrations were lower. (I), stabilized sera underwent several freeze–thaw cycles before nucleosome measurements. (J), deep-frozen sera were thawed 2 and 12 h before measurement and were, meanwhile, stored at 4 and 25 °C. Freezing–thawing had no impact on nucleosome concentrations.

In the second experiment, we investigated the influence of agitation by vortex-mixing the samples for 5, 10, and 30 s or, alternatively, by rolling them in a slow overhead roller for 15 and 30 min. Subsequently, all of the samples were incubated at 25 or 37 °C for 4 h before they were frozen at –70 °C. Neither after shaking nor after rolling the samples did we observe major changes in the concentrations of stabilized sera, particularly if they were incubated at 25 °C for 4 h (median SD <5%). However, after additional incubation at 37 °C for 4 h, the values tended to be lower (median SD up to 20%; Fig. 1Up , G and H).

We then analyzed the influence of freezing and thawing on the stabilized sera. Repeated refreezing (up to 3 times at –70 °C) led to only minor changes in the concentrations (median SD <10%). Thawing the samples at various time points before measurements (2 and 12 h) and storage at various temperatures (4 and 25 °C) also had no impact on the values (median SD <10%; Fig. 1Up , I and J).

Our results indicate that the concentration of nucleosomes in sera stabilized with 10 mmol/L EDTA is not influenced by preanalytical conditions such as time of transportation, moderate temperature (4–25 °C), shaking, rolling, and several freeze–thaw cycles. However, long-term exposure to high temperatures (37 °C) should be avoided as it can cause a notable decrease in the measured nucleosome concentration. This might be attributable to enhanced activation of serum nucleases or by direct thermal damage of the nucleosomes.

When these precautions are taken and the preanalytical protocol is followed, including early centrifugation and subsequent stabilization of the sera with EDTA, samples can be shipped by mail without adverse effects on the results of nucleosome measurements.


Acknowledgments

The nucleosome assays were provided by Roche Diagnostics, Germany.


References

  1. Leon SA, Shapiro B, Sklaroff DM, Yaros MJ. Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res 1977;37:646-650.[Abstract/Free Full Text]
  2. Shapiro B, Chakrabarty M, Cohn EM, Leon SA. Determination of circulating DNA levels in patients with benign or malignant gastrointestinal disease. Cancer 1983;51:2116-2120.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  3. Holdenrieder S, Stieber P, Bodenmueller H, Busch M, Fertig G, Fuerst H, et al. Nucleosomes in serum of patients with benign and malignant diseases. Int J Cancer 2001;95:114-120.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  4. Zeerleder S, Zwart B, Wuillemin WA, Aarden LA, Groeneveld AB, Caliezi C, et al. Elevated nucleosome levels in systemic inflammation and sepsis. Crit Care Med 2003;31:1947-1951.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  5. Lo YMD, Tein MSC, Pang CCP, Yeung Ck, Tong KL, Hjelm NM. Presence of donor-specific DNA in plasma of kidney and liver transplant recipients. Lancet 1998;351:1329-1330.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  6. Lo YMD, Rainer TH, Chan LYS, Hjelm NM, Cocks RA. Plasma DNA as a prognostic marker in trauma patients. Clin Chem 2000;46:319-323.[Abstract/Free Full Text]
  7. Rainer TH, Wong LKS, Lam W, Yuen E, Lam NYL, Metrewel C, et al. Prognostic use of circulating plasma nucleic acid concentrations in patients with acute stroke. Clin Chem 2003;49:562-569.[Abstract/Free Full Text]
  8. Ziegler A, Zangemeister-Wittke U, Stahel RA. Circulating DNA: a new diagnostic gold mine?. Cancer Treatment Rev 2002;28:255-271.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  9. Holdenrieder S, Stieber P. Therapy control in oncology by circulating nucleosomes. Ann N Y Acad Sci 2004;1022:211-216.[Abstract/Free Full Text]
  10. Lo YM, Chan LY, Chan AT, Leung SF, Lo KW, Zhang J, et al. Quantitative and temporal correlation between circulating cell-free Epstein-Barr virus DNA and tumor recurrence in nasopharyngeal carcinoma. Cancer Res 1999;59:5452-5455.[Abstract/Free Full Text]
  11. Holdenrieder S, Stieber P, von Pawel J, Raith H, Nagel D, Feldmann K, et al. Circulating nucleosomes predict the response to chemotherapy in patients with advanced non small cell lung cancer. Clin Cancer Res 2004;10:5981-5987.[Abstract/Free Full Text]
  12. Gautschi O, Bigosch C, Huegli B, Jermann M, Marx A, Chasse E, et al. Circulating deoxyribonucleic acid as prognostic marker in non-small-cell lung cancer patients undergoing chemotherapy. J Clin Oncol 2004;22:4157-4164.[Abstract/Free Full Text]
  13. Rumore PM, Steinman CR. Endogenous circulating DNA in systemic lupus erythematosus. Occurrence as multimeric complexes bound to histone. J Clin Invest 1990;86:69-74.
  14. Chan KC, Zhang J, Chan AT, Lei KI, Leung SF, Chan LY, et al. Molecular characterization of circulating EBV-DNA in the plasma of nasopharyngeal carcinoma and lymphoma patients. Cancer Res 2003;63:2028-2032.[Abstract/Free Full Text]
  15. Luger K. Structure and dynamic behavior of nucleosomes. Curr Opin Genet Dev 2003;13:127-135.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  16. Ng EK, Tsui NB, Lam NY, Chiu RW, Yu SC, Wong SC, et al. Presence of filterable and nonfilterable mRNA in the plasma of cancer patients and healthy individuals. Clin Chem 2002;48:1212-1217.[Abstract/Free Full Text]
  17. Holdenrieder S, Stieber P, Bodenmueller H, Fertig G, Fuerst H, Schmeller N, et al. Nucleosomes in serum as a marker for cell death. Clin Chem Lab Med 2001;39:596-605.[CrossRef][ISI][Medline] [Order article via Infotrieve]



The following articles in journals at HighWire Press have cited this article:


Home page
Clin. Chem.Home page
U. Deligezer, E. E. Akisik, N. Erten, and N. Dalay
Sequence-Specific Histone Methylation Is Detectable on Circulating Nucleosomes in Plasma
Clin. Chem., July 1, 2008; 54(7): 1125 - 1131.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Holdenrieder, S.
Right arrow Articles by Stieber, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Holdenrieder, S.
Right arrow Articles by Stieber, P.
Related Collections
Right arrow Molecular Diagnostics and Genetics


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS